ASX:PABPatrys Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Patrys Limited Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add A$0.01 0.00 (0.00 %) (As of 05/13/2020) Add Compare Share Today's RangeA$0.01Now: A$0.01▼A$0.0150-Day Range N/A52-Week RangeA$0.01Now: A$0.01▼A$0.04Volume250,000 shsAverage VolumeN/AMarket Capitalization$12.87 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsEarningsInsider TradesHeadlines Patrys Limited, a biopharmaceutical company, develops products for the treatment of cancer in Australia. The company develops PAT-SM6, a natural human antibody that is in Phase I/IIa clinical trials used for the treatment of various types of cancer, including solid tumors, such as melanoma, breast, colon, and pancreatic, as well as blood-based cancers, such as multiple myeloma; and PAT-SC1, a clinical trial antibody that treats gastric cancer. It also develops PAT-LM1, a natural human antibody that is used for the treatment of colon, lung, breast, ovary, and pancreatic cancers; and Deoxymab 3E10, a lupus autoantibody that penetrates live cell nuclei by binding to DNA or its precursors outside of cells and then following it into cell nuclei through a nucleoside transporter. The company was founded in 2006 and is based in South Melbourne, Australia.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Patrys. Previous Next 2.6 Community Rank Outperform VotesPatrys has received 18 “outperform” votes. (Add your “outperform” vote.)Underperform VotesPatrys has received 17 “underperform” votes. (Add your “underperform” vote.)Community SentimentPatrys has received 51.43% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Patrys and other stocks. Vote “Outperform” if you believe PAB will outperform the S&P 500 over the long term. Vote “Underperform” if you believe PAB will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldPatrys does not currently pay a dividend.Dividend GrowthPatrys does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Patrys insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Patrys is -4.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Patrys is -4.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioPatrys has a P/B Ratio of 2.40. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.52 out of 5 stars Industry, Sector and Symbol Stock Exchange ASX Industry Drug Manufacturers - Major Sub-IndustryN/A SectorMedical Current SymbolASX:PAB Previous Symbol CUSIPN/A CIKN/A Webwww.patrys.com Phone61 3 9692 7222Debt Debt-to-Equity RatioN/A Current Ratio11.18 Quick Ratio11.02Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$746,241.00 Price / Sales17.25 Cash FlowA$0.01 per share Price / Cash Flow2.40 Book ValueA$0.01 per share Price / Book2.40Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares1,072,590,016Market Cap$12.87 million Next Earnings DateN/A OptionableNot Optionable Receive PAB News and Ratings via Email Sign-up to receive the latest news and ratings for PAB and its competitors with MarketBeat's FREE daily newsletter. Patrys (ASX:PAB) Frequently Asked Questions How were Patrys' earnings last quarter? Patrys Limited (ASX:PAB) issued its earnings results on Wednesday, February, 20th. The company reported $0.00 EPS for the quarter. View Patrys' earnings history. Has Patrys been receiving favorable news coverage? News stories about PAB stock have been trending very negative this week, InfoTrie reports. The research firm ranks the sentiment of press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Patrys earned a media sentiment score of -3.1 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the immediate future. View the latest news aboutPatrys. Who are some of Patrys' key competitors? Some companies that are related to Patrys include Futura Medical (FUM), NanoViricides (NNVC), Vita Life Sciences (VLS), Pharmaxis (PXS), Avivagen (VIV), Antisense Therapeutics (ANP), Sareum (SAR), China Pharma (CPHI), Cathay International (CTI), N4 Pharma (N4P), Bayer (BAYN), HedgePath Pharmaceuticals (MAYNF), OTSUKA HOLDINGS/ADR (OTSKY), Roche (RHHVF) and Sanofi (SNYNF). View all competitors. What other stocks do shareholders of Patrys own? Based on aggregate information from My MarketBeat watchlists, some companies that other Patrys investors own include Woolworths Group (WOW), Proteomics Int Lab (PIQ), Insurance Australia Group (IAG) and Bendigo and Adelaide Bank (BEN). Who are Patrys' key executives? Patrys' management team includes the following people: Dr. James A. Campbell Ph.D., MBA, MD, CEO & DirectorMs. Melanie Jaye Leydin C.A., B.Bus, CA, Company Sec. (Age 46)Dr. Deanne Greenwood GAICD, Ph.D., MBA, VP of Bus. Devel. & Intellectual Property What is Patrys' stock symbol? Patrys trades on the ASX under the ticker symbol "PAB." What is Patrys' stock price today? One share of PAB stock can currently be purchased for approximately A$0.01. How big of a company is Patrys? Patrys has a market capitalization of $12.87 million and generates $746,241.00 in revenue each year. What is Patrys' official website? The official website for Patrys is www.patrys.com. How can I contact Patrys? The company can be reached via phone at 61 3 9692 7222. This page was last updated on 6/3/2020 by MarketBeat.com Staff
